Immediate Impact
38 standout
Citing Papers
Liquid biopsy in cancer: current status, challenges and future prospects
2024 Standout
Properties of FDA-approved small molecule protein kinase inhibitors: A 2024 update
2024 Standout
Works of Yan Su being referenced
400P Impact of regorafenib dose optimization on comparative outcomes in the treatment of relapsed/refractory metastatic colorectal cancer (mCRC)
2022
Dynamic alterations of plasma cell free DNA in response to chemotherapy in children with neuroblastoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yan Su | 147 | 107 | 81 | 106 | 57 | 434 | |
| Sucheta Vaidya | 137 | 107 | 93 | 48 | 39 | 402 | |
| Naoki Kurita | 63 | 90 | 88 | 64 | 55 | 452 | |
| Hiroyuki Shichino | 131 | 130 | 62 | 62 | 52 | 471 | |
| Antonio Acquaviva | 73 | 162 | 149 | 50 | 37 | 451 | |
| Helen Toledano | 130 | 125 | 69 | 82 | 51 | 475 | |
| Vincent Camus | 75 | 100 | 201 | 147 | 46 | 505 | |
| Ulrike Pöetschger | 270 | 142 | 120 | 151 | 36 | 502 | |
| Kazuyoshi Kajimoto | 80 | 124 | 152 | 35 | 45 | 480 | |
| Dae Ro Choi | 56 | 94 | 162 | 69 | 43 | 452 | |
| Öner Doğan | 115 | 76 | 125 | 25 | 54 | 389 |
All Works
Login with ORCID to disown or claim papers
Loading papers...